NIM
SWTX

NEOS Investment Management’s SpringWorks Therapeutics SWTX Stock Holding History

NEOS Investment Management’s Portfolio SWTX Stock Details SWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-30,811
Closed -$1.11M – 618
2024
Q4 		$1.11M Buy
30,811
+10,433
+51% +$365K 0.03% 391
2024
Q3 		$653K Buy
20,378
+4,888
+32% +$183K 0.02% 451
2024
Q2 		$584K Buy
15,490
+10,040
+184% +$423K 0.02% 418
2024
Q1 		$268K Buy
+5,450
New +$252K 0.02% 506

Other funds holding SWTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

NEOS Investment Management's SWTX Position: Q1 2025 in Review

NEOS Investment Management sold out of SpringWorks Therapeutics (SWTX) in Q1 2025, closing a stake of 30,811 shares — an estimated $1.11M sold.

NEOS Investment Management first reported a position in SWTX in Q1 2024 and held it in 4 quarters. The position peaked at $1.11M in Q4 2024. 306 funds tracked by Wall St. Rank hold SWTX as of Q1 2025.

  • NEOS Investment Management reported no remaining SpringWorks Therapeutics position as of Q1 2025 after selling out during the quarter.
  • NEOS Investment Management sold 30,811 SpringWorks Therapeutics shares in Q1 2025, an estimated $1.11M.
  • NEOS Investment Management first reported a position in SpringWorks Therapeutics in Q1 2024 and held it in 4 quarters.
  • NEOS Investment Management's SpringWorks Therapeutics position peaked at $1.11M in Q4 2024.
  • 306 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q1 2025.

Based on NEOS Investment Management's 13F filing for Q1 2025, filed 15 May 2025.